Skip to content
Kobus Louw
- Sarepta Therapeutics (NASDAQ:SRPT) has closed on a $600M senior secured revolving credit facility made possible with a bank syndicate.
- JP Morgan Chase (JPM) served as lead arranger and joint bookrunner.
- The credit facility “supplements our strong balance sheet and allows for